{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T18:08:41Z","timestamp":1783447721033,"version":"3.55.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Research and Development Program of Shandong Province","award":["2016GSF201152"],"award-info":[{"award-number":["2016GSF201152"]}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2017MH028"],"award-info":[{"award-number":["ZR2017MH028"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemico-Biological Interactions"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.cbi.2018.08.010","type":"journal-article","created":{"date-parts":[[2018,8,17]],"date-time":"2018-08-17T12:55:40Z","timestamp":1534510540000},"page":"18-27","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["BENC-511, a novel PI3K inhibitor, suppresses metastasis of non-small cell lung cancer cells by modulating \u03b2-catenin\/ZEB1 regulatory loop"],"prefix":"10.1016","volume":"294","author":[{"given":"Qianyun","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lichun","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhui","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanna","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuzhen","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cbi.2018.08.010_bib1","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.ijrobp.2017.03.010","article-title":"Treatment-related toxicity in patients with early-stage non-small cell lung cancer and coexisting interstitial lung disease: a systematic review","volume":"98","author":"Chen","year":"2017","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.cbi.2018.08.010_bib2","doi-asserted-by":"crossref","first-page":"676","DOI":"10.6004\/jnccn.2015.0201","article-title":"Targeted\/emerging therapies for metastatic non-small cell lung cancer","volume":"13","author":"Horn","year":"2015","journal-title":"J. Natl. Compr. Canc. Netw."},{"key":"10.1016\/j.cbi.2018.08.010_bib3","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3389\/fmed.2017.00036","article-title":"Second-line treatment of non-small cell lung cancer: focus on the clinical development of dacomitinib","volume":"4","author":"Zugazagoitia","year":"2017","journal-title":"Front. Med."},{"key":"10.1016\/j.cbi.2018.08.010_bib4","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.critrevonc.2011.01.007","article-title":"Targeting phosphoinositide 3-kinase signalling in lung cancer","volume":"80","author":"Wojtalla","year":"2011","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.cbi.2018.08.010_bib5","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/jcp.22722","article-title":"Potential mechanism of interleukin-8 production from lung cancer cells: an involvement of EGF-EGFR-PI3K-Akt-Erk pathway","volume":"227","author":"Zhang","year":"2012","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.cbi.2018.08.010_bib6","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/nrc2664","article-title":"Targeting PI3K signalling in cancer: opportunities, challenges and limitations","volume":"9","author":"Engelman","year":"2009","journal-title":"Nat. Rev. Canc."},{"key":"10.1016\/j.cbi.2018.08.010_bib7","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1038\/nm.3336","article-title":"The epigenetics of epithelial-mesenchymal plasticity in cancer","volume":"19","author":"Tam","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.cbi.2018.08.010_bib8","doi-asserted-by":"crossref","first-page":"E37","DOI":"10.3390\/jcm5030037","article-title":"New insights into the crossroads between EMT and stemness in the context of cancer","volume":"5","author":"Fabregat","year":"2016","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.cbi.2018.08.010_bib9","doi-asserted-by":"crossref","first-page":"10697","DOI":"10.18632\/oncotarget.4037","article-title":"EMT, CTCs and CSCs in tumor relapse and drug-resistance","volume":"6","author":"Mitra","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.cbi.2018.08.010_bib10","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1111\/j.1349-7006.2011.02199.x","article-title":"Zinc finger E-box binding homeobox 1 promotes vasculogenic mimicry in colorectal cancer through induction of epithelial-to-mesenchymal transition","volume":"103","author":"Liu","year":"2012","journal-title":"Canc. Sci."},{"key":"10.1016\/j.cbi.2018.08.010_bib11","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1111\/jcmm.12851","article-title":"The relationship between vasculogenic mimicry and epithelial-mesenchymal transitions","volume":"20","author":"Liu","year":"2016","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.cbi.2018.08.010_bib12","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.3892\/etm.2017.4665","article-title":"Hypoxia-inducible factor 1\u03b1 participates in hypoxia-induced epithelial-mesenchymal transition via response gene to complement 32","volume":"14","author":"Zhu","year":"2017","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.cbi.2018.08.010_bib13","first-page":"272","article-title":"The biological kinship of hypoxia with CSC and EMT and their relationship with deregulated expression of miRNAs and tumor aggressiveness","volume":"1826","author":"Bao","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.cbi.2018.08.010_bib14","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.biopha.2016.03.010","article-title":"The hypoxia-related signaling pathways of vasculogenic mimicry in tumor treatment","volume":"80","author":"Li","year":"2016","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.cbi.2018.08.010_bib15","doi-asserted-by":"crossref","first-page":"E17","DOI":"10.3390\/jcm5020017","article-title":"Role of EMT in metastasis and therapy resistance","volume":"5","author":"Smith","year":"2016","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.cbi.2018.08.010_bib16","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1182\/blood-2010-05-284810","article-title":"A small-molecule inhibitor of D-cyclin transactivation displays preclinical efficacy in myeloma and leukemia via phosphoinositide 3-kinase pathway","volume":"117","author":"Mao","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.cbi.2018.08.010_bib17","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1016\/j.bmcl.2013.03.097","article-title":"Preparation of S14161 and its analogues and the discovery of 6-bromo-8-ethoxy-3-nitro-2H-chromene as a more potent antitumor agent in vitro","volume":"23","author":"Yin","year":"2013","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.cbi.2018.08.010_bib18","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1756-8722-7-9","article-title":"Identification of a promising PI3K inhibitor for the treatment of multiple myeloma through the structural optimization","volume":"7","author":"Han","year":"2014","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.cbi.2018.08.010_bib19","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.toxlet.2014.05.003","article-title":"A novel PI3K inhibitor displays potent preclinical activity against an androgen-independent and PTEN-deficient prostate cancer model established from the cell line PC3","volume":"228","author":"Shi","year":"2014","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.cbi.2018.08.010_bib20","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.fct.2013.02.032","article-title":"Inhibition of angiogenesis and invasion by DMBT is mediated by downregulation of VEGF and MMP-9 through Akt pathway in MDA-MB-231 breast cancer cells","volume":"56","author":"Tang","year":"2013","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.cbi.2018.08.010_bib21","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.cbi.2014.08.004","article-title":"Inhibition of invasion and metastasis by DMBT, a novel trehalose derivative, through Akt\/GSK-3beta\/beta-catenin pathway in B16BL6 cells","volume":"222","author":"Tang","year":"2014","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.cbi.2018.08.010_bib22","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3109\/14756366.2016.1161620","article-title":"Matrix metalloproteinases (MMPs), the main extracellular matrix (ECM) enzymes in collagen degradation, as a target for anticancer drugs","volume":"31","author":"Jab\u0142o\u0144ska-Trypu\u0107","year":"2016","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.cbi.2018.08.010_bib23","first-page":"1175","article-title":"Preselection of EGFR mutations in non-small-cell lung cancer patients by immunohistochemistry: comparison with DNA-sequencing, EGFR wild-type expression, gene copy number gain and clinicopathological data","volume":"58","author":"Gaber","year":"2017","journal-title":"Rom. J. Morphol. Embryol."},{"key":"10.1016\/j.cbi.2018.08.010_bib24","first-page":"322","article-title":"Preclinical rationale for PI3K\/Akt\/mTOR pathway inhibitors as therapy for epidermal growth factor receptor inhibitor-resistant non-small-cell lung cancer","volume":"14","author":"Gadgeel","year":"2013","journal-title":"Clin. Lung Canc."},{"key":"10.1016\/j.cbi.2018.08.010_bib25","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1007\/s13277-014-2667-5","article-title":"Combine MEK inhibition with PI3K\/mTOR inhibition exert inhibitory tumor growth effect on KRAS and PIK3CA mutation CRC xenografts due to reduced expression of VEGF and matrix metallopeptidase-9","volume":"36","author":"E","year":"2015","journal-title":"Tumour Biol"},{"key":"10.1016\/j.cbi.2018.08.010_bib26","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1038\/nrd4204","article-title":"PI3K and cancer: lessons, challenges and opportunities","volume":"13","author":"Fruman","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.cbi.2018.08.010_bib27","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.3892\/ol.2016.4092","article-title":"Epithelial-mesenchymal interconversions and the regulatory function of the ZEB family during the development and progression of ovarian cancer","volume":"11","author":"Wu","year":"2016","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.cbi.2018.08.010_bib28","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1158\/0008-5472.CAN-17-2476","article-title":"Pleiotropic roles for ZEB1 in cancer","volume":"78","author":"Caramel","year":"2018","journal-title":"Can. Res."},{"key":"10.1016\/j.cbi.2018.08.010_bib29","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1146\/annurev-cellbio-111315-125150","article-title":"Mechanical control of epithelial-to-mesenchymal transitions in development and cancer","volume":"32","author":"Przybyla","year":"2016","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"10.1016\/j.cbi.2018.08.010_bib30","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1158\/0008-5472.CAN-05-1988","article-title":"Restoring E-cadherin expression increases sensitivity to epidermal growth factor receptor inhibitors in lung cancer cell lines","volume":"66","author":"Witta","year":"2006","journal-title":"Can. Res."},{"key":"10.1016\/j.cbi.2018.08.010_bib31","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.cell.2013.06.005","article-title":"Poised chromatin at the ZEB1 promoter enables breast cancer cell plasticity and enhances tumorigenicity","volume":"154","author":"Chaffer","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.cbi.2018.08.010_bib32","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/cbf.2876","article-title":"The Wnt\/\u03b2-catenin\/T-cell factor 4 pathway up-regulates high-mobility group A1 expression in colon cancer","volume":"31","author":"Bush","year":"2013","journal-title":"Cell Biochem. Funct."},{"key":"10.1016\/j.cbi.2018.08.010_bib33","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.biopha.2015.05.004","article-title":"Knockdown of type I insulin-like growth factor receptor inhibits human colorectal cancer cell growth and downstream PI3K\/Akt, WNT\/beta-catenin signal pathways","volume":"73","author":"Zhang","year":"2015","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.cbi.2018.08.010_bib34","first-page":"748","article-title":"Wnt signaling through Snail1 and Zeb1 regulates bone metastasis in lung cancer","volume":"5","author":"Yang","year":"2015","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.cbi.2018.08.010_bib35","first-page":"8114","article-title":"DDR2 facilitates papillary thyroid carcinoma epithelial mesenchymal transition by activating ERK2\/Snail1 pathway","volume":"14","author":"Liang","year":"2017","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.cbi.2018.08.010_bib36","doi-asserted-by":"crossref","first-page":"19204","DOI":"10.1073\/pnas.1108977108","article-title":"\u03b2-catenin\/TCF4 complex induces the epithelial-to-mesenchymal transition (EMT)-activator ZEB1 to regulate tumor invasiveness","volume":"108","author":"S\u00e1nchez-Till\u00f3","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A"}],"container-title":["Chemico-Biological Interactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279718307919?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279718307919?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T13:49:30Z","timestamp":1757857770000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009279718307919"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":36,"alternative-id":["S0009279718307919"],"URL":"https:\/\/doi.org\/10.1016\/j.cbi.2018.08.010","relation":{},"ISSN":["0009-2797"],"issn-type":[{"value":"0009-2797","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"BENC-511, a novel PI3K inhibitor, suppresses metastasis of non-small cell lung cancer cells by modulating \u03b2-catenin\/ZEB1 regulatory loop","name":"articletitle","label":"Article Title"},{"value":"Chemico-Biological Interactions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cbi.2018.08.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}